New insights into type I interferon and the immunopathogenesis of persistent viral infections

被引:38
|
作者
Snell, Laura M. [1 ,2 ]
Brooks, David G. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA
[3] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada
基金
美国国家卫生研究院;
关键词
CHRONIC HEPATITIS-C; CD8; T-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMACYTOID DENDRITIC CELLS; FOLLICULAR HELPER; IMMUNE ACTIVATION; CLONAL EXPANSION; HIV; EXPRESSION; RESPONSES;
D O I
10.1016/j.coi.2015.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most viruses generate potent T cell responses that rapidly control infection. However, certain viruses can subvert the immune response to establish persistent infections. The inability to clear virus induces an immunosuppressive program leading to the sustained expression of many immunoregulatory molecules that down-regulate T cell responses. Further, viral persistence is associated with multiple immune dysfunctions including lymphoid disorganization, defective antigen presentation, aberrant B cell responses and hypergammaglobulinemia. Although best known for its antiviral activity, recent data has highlighted the role of type I IFN (IFN-I) signaling as a central mediator of immunosuppression during viral persistence. It is also becoming increasingly apparent that many of the immune dysfunctions during persistent virus infection can be attributed directly or indirectly to the effects of chronic IFN-I signaling. This review explores the increasingly complex role of IFN-I in the regulation of immunity against persistently replicating virus infections and examines current and potential uses of IFN-I and blockade of IFN-I signaling to dampen chronic inflammation and activation in the clinic.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [1] Decoding the complexity of type I interferon to treat persistent viral infections
    Wilson, Elizabeth B.
    Brooks, David G.
    TRENDS IN MICROBIOLOGY, 2013, 21 (12) : 634 - 640
  • [2] The first answer to viral infections: Type I interferon
    Pichlmair, A
    Pollak, M
    Bergthaler, A
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2004, 117 (7-8): : 252 - 265
  • [3] Type I Interferon in Children with Viral or Bacterial Infections
    Trouillet-Assant, Sophie
    Viel, Sebastien
    Ouziel, Antoine
    Boisselier, Lucille
    Rebaud, Philippe
    Basmaci, Romain
    Droz, Nina
    Belot, Alexandre
    Pons, Sylvie
    Brengel-Pesce, Karen
    Gillet, Yves
    Javouhey, Etienne
    CLINICAL CHEMISTRY, 2020, 66 (06) : 802 - 808
  • [4] The host type I interferon response to viral and bacterial infections
    Andrea K PERRY
    Gang CHEN
    Dahai ZHENG
    Hong TANG
    Genhong CHENG
    Cell Research, 2005, 15 : 407 - 422
  • [5] The host type I interferon response to viral and bacterial infections
    Andrea K. PERRY
    Cell Research, 2005, (06) : 407 - 422
  • [6] The host type I interferon response to viral and bacterial infections
    Perry, AK
    Chen, G
    Zheng, DH
    Tang, H
    Cheng, GH
    CELL RESEARCH, 2005, 15 (06) : 407 - 422
  • [7] The type I interferon response during viral infections: a "SWOT" analysis
    Gaajetaan, Giel R.
    Bruggeman, Cathrien A.
    Stassen, Frank R.
    REVIEWS IN MEDICAL VIROLOGY, 2012, 22 (02) : 122 - 137
  • [8] Interferon type-I responses in primary and secondary viral infections
    Alsharifi, Mohammed
    Regner, Matthias
    Blanden, Robert
    Lobigs, Mario
    Lee, Eva
    Koskinen, Aulikki
    Muellbacher, Arno
    CYTOKINE, 2007, 39 (01) : 1 - 1
  • [9] INTERFERENCE AND INTERFERON IN PERSISTENT VIRAL INFECTIONS OF CELL CULTURES
    HENLE, W
    JOURNAL OF IMMUNOLOGY, 1963, 91 (02): : 145 - +
  • [10] Interfering with type I Interferon A novel approach to purge persistent viral infection
    Wilson, Elizabeth B.
    Brooks, David G.
    CELL CYCLE, 2013, 12 (18) : 2919 - 2920